Selected publications

1. Poh AR, O'Donoghue RJ, Ernst M, Putoczki TL. Mouse models for gastric cancer: Matching models to biological questions. J Gastroenterol Hepatol. 2016 Jan 25. doi: 10.1111/jgh.13297. [Epub ahead of print] Review. PMID: 26809278
2. Rankin LC, Girard-Madoux MJ, Seillet C, Mielke LA, Kerdiles Y, Fenis A, Wieduwild E, Putoczki T, Mondot S, Lantz O, Demon D, Papenfuss AT, Smyth GK, Lamkanfi M, Carotta S, Renauld JC, Shi W, Carpentier S, Soos T, Arendt C, Ugolini S, Huntington ND, Belz GT, Vivier E. Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nat Immunol. 2016 Feb;17(2):179-86. doi: 10.1038/ni.3332. Epub 2015 Nov 30. PMID: 26595889
3. Mielke L, Preaudet A, Belz G, Putoczki T. Confocal laser endomicroscopy to monitor the colonic mucosa of mice. J Immunol Methods. 2015 Jun;421:81-8. doi: 10.1016/j.jim.2015.04.012. Epub 2015 May 8. PMID: 25960174
4. Ernst M, Preaudet A, Putoczki T. Non-invasive assessment of the efficacy of new therapeutics for intestinal pathologies using serial endoscopic imaging of live mice. J Vis Exp. 2015 Mar 10;(97). doi: 10.3791/52383. PMID: 25867916 
5. Ernst M, Putoczki TL. Molecular Pathways: IL11 as a Tumor-Promoting Cytokine-Translational Implications for Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Jul 29. PMID: 25074610. Epub 2014/07/31. Eng.
6. Ernst M, Thiem S, Nguyen PM, Eissmann M, Putoczki TL. Epithelial gp130/Stat3 functions: an intestinal signaling node in health and disease. Seminars in immunology. 2014 Feb;26(1):29-37. PMID: 24434062. Epub 2014/01/18. eng.
7. Stuart E, Buchert M, Putoczki T, Thiem S, Farid R, Elzer J, Huszar D, Waring PM, Phesse TJ, Ernst M. Therapeutic inhibition of Jak activity inhibits progression of gastrointestinal tumors in mice. Molecular cancer therapeutics. 2014 Feb;13(2):468-74. PMID: 24398427. Epub 2014/01/09. eng.
8. Putoczki TL, Thiem S, Loving A, Busuttil RA, Wilson NJ, Ziegler PK, Nguyen PM, Preaudet A, Farid R, Edwards KM, Boglev Y, Luwor RB, Jarnicki A, Horst D, Boussioutas A, Heath JK, Sieber OM, Pleines I, Kile BT, Nash A, Greten FR, McKenzie BS, Ernst M. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Cancer cell. 2013 Aug 12;24(2):257-71. PMID: 23948300. Epub 2013/08/21. eng.
9. Bollrath J, Phesse TJ, von Burstin VA, Putoczki T, Bennecke M, Bateman T, Nebelsiek T, Lundgren-May T, Canli O, Schwitalla S, Matthews V, Schmid RM, Kirchner T, Arkan MC, Ernst M, Greten FR. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer cell. 2009 Feb 3;15(2):91-102. PMID: 19185844. Epub 2009/02/03. eng.
10. Putoczki T, Ernst M. More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer. Journal of leukocyte biology. 2010 Dec;88(6):1109-17. PMID: 20610798. Epub 2010/07/09. eng.